

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.74088935 |
| 2 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.03056317 |
| 3 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.48402393 |
| 4 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.48402393 |
| 5 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.33923575 |
| 6 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.28745859 |
| 7 | negative regulation of cell killing (GO:0031342) | 4.28745859 |
| 8 | neutrophil activation involved in immune response (GO:0002283) | 4.28610586 |
| 9 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.27433954 |
| 10 | cellular response to zinc ion (GO:0071294) | 4.18155087 |
| 11 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.11998015 |
| 12 | immunoglobulin mediated immune response (GO:0016064) | 4.07807972 |
| 13 | B cell receptor signaling pathway (GO:0050853) | 4.06424573 |
| 14 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.89012003 |
| 15 | detection of bacterium (GO:0016045) | 3.85526676 |
| 16 | regulation of B cell differentiation (GO:0045577) | 3.83168242 |
| 17 | positive regulation of B cell differentiation (GO:0045579) | 3.80165623 |
| 18 | respiratory burst (GO:0045730) | 3.73436808 |
| 19 | positive regulation of interferon-alpha production (GO:0032727) | 3.71611921 |
| 20 | detection of other organism (GO:0098543) | 3.68710647 |
| 21 | cytidine metabolic process (GO:0046087) | 3.65514239 |
| 22 | cytidine catabolic process (GO:0006216) | 3.65514239 |
| 23 | cytidine deamination (GO:0009972) | 3.65514239 |
| 24 | defense response to protozoan (GO:0042832) | 3.64799907 |
| 25 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.57083815 |
| 26 | ribosomal small subunit assembly (GO:0000028) | 3.50521785 |
| 27 | regulation of interferon-alpha production (GO:0032647) | 3.49417598 |
| 28 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.41499346 |
| 29 | sequestering of actin monomers (GO:0042989) | 3.40759203 |
| 30 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.37788666 |
| 31 | cellular response to interferon-beta (GO:0035458) | 3.37032136 |
| 32 | response to protozoan (GO:0001562) | 3.35673204 |
| 33 | response to type I interferon (GO:0034340) | 3.34076715 |
| 34 | type I interferon signaling pathway (GO:0060337) | 3.33012298 |
| 35 | cellular response to type I interferon (GO:0071357) | 3.33012298 |
| 36 | response to interferon-beta (GO:0035456) | 3.28263842 |
| 37 | B cell mediated immunity (GO:0019724) | 3.25068357 |
| 38 | positive thymic T cell selection (GO:0045059) | 3.17390376 |
| 39 | modulation by symbiont of host defense response (GO:0052031) | 3.16361743 |
| 40 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.16361743 |
| 41 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.16361743 |
| 42 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.16361743 |
| 43 | modulation by symbiont of host immune response (GO:0052553) | 3.16361743 |
| 44 | positive regulation by symbiont of host defense response (GO:0052509) | 3.16361743 |
| 45 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.15100727 |
| 46 | NIK/NF-kappaB signaling (GO:0038061) | 3.14179639 |
| 47 | leukocyte aggregation (GO:0070486) | 3.13513478 |
| 48 | response to peptidoglycan (GO:0032494) | 3.13008596 |
| 49 | cellular response to exogenous dsRNA (GO:0071360) | 3.12050993 |
| 50 | neutrophil activation (GO:0042119) | 3.09135253 |
| 51 | T-helper 1 type immune response (GO:0042088) | 3.09090229 |
| 52 | granulocyte activation (GO:0036230) | 3.03298995 |
| 53 | negative regulation of phagocytosis (GO:0050765) | 3.00966142 |
| 54 | mast cell activation (GO:0045576) | 2.99363588 |
| 55 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.98494071 |
| 56 | mature B cell differentiation (GO:0002335) | 2.97050541 |
| 57 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.96853625 |
| 58 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.96722062 |
| 59 | myeloid dendritic cell activation (GO:0001773) | 2.95933259 |
| 60 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.94624876 |
| 61 | mature B cell differentiation involved in immune response (GO:0002313) | 2.91555132 |
| 62 | detection of external biotic stimulus (GO:0098581) | 2.90698657 |
| 63 | regulation of gamma-delta T cell activation (GO:0046643) | 2.90063627 |
| 64 | regulation of mast cell degranulation (GO:0043304) | 2.88975946 |
| 65 | positive regulation of antigen processing and presentation (GO:0002579) | 2.88813803 |
| 66 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.88525190 |
| 67 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.88339421 |
| 68 | natural killer cell mediated immunity (GO:0002228) | 2.86656572 |
| 69 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.86656572 |
| 70 | T cell migration (GO:0072678) | 2.86204336 |
| 71 | myeloid dendritic cell differentiation (GO:0043011) | 2.85446036 |
| 72 | macrophage activation involved in immune response (GO:0002281) | 2.84823895 |
| 73 | actin nucleation (GO:0045010) | 2.84730552 |
| 74 | germinal center formation (GO:0002467) | 2.83511614 |
| 75 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.83317000 |
| 76 | myeloid cell activation involved in immune response (GO:0002275) | 2.80722644 |
| 77 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.78072513 |
| 78 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.77033852 |
| 79 | negative regulation of interleukin-12 production (GO:0032695) | 2.70780862 |
| 80 | response to muramyl dipeptide (GO:0032495) | 2.66818685 |
| 81 | cellular response to interferon-gamma (GO:0071346) | 2.66622286 |
| 82 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.66053904 |
| 83 | lymph node development (GO:0048535) | 2.65940295 |
| 84 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.65214198 |
| 85 | regulation of cellular extravasation (GO:0002691) | 2.64864091 |
| 86 | positive regulation of cytokine biosynthetic process (GO:0042108) | 2.64424284 |
| 87 | negative regulation of innate immune response (GO:0045824) | 2.62103247 |
| 88 | positive regulation of interferon-beta production (GO:0032728) | 2.61887968 |
| 89 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.58389614 |
| 90 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.57828887 |
| 91 | negative thymic T cell selection (GO:0045060) | 2.56750361 |
| 92 | positive regulation of macrophage differentiation (GO:0045651) | 2.56368912 |
| 93 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.55960119 |
| 94 | T cell costimulation (GO:0031295) | 2.54391639 |
| 95 | viral transcription (GO:0019083) | 2.54307766 |
| 96 | response to interferon-gamma (GO:0034341) | 2.54255144 |
| 97 | positive regulation of interleukin-12 production (GO:0032735) | 2.53428657 |
| 98 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.53409119 |
| 99 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.52619372 |
| 100 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.52353330 |
| 101 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.52316699 |
| 102 | regulation of response to interferon-gamma (GO:0060330) | 2.52275119 |
| 103 | cellular extravasation (GO:0045123) | 2.51785768 |
| 104 | regulation of antigen processing and presentation (GO:0002577) | 2.50642215 |
| 105 | lymphocyte costimulation (GO:0031294) | 2.50302461 |
| 106 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.50227320 |
| 107 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.50169804 |
| 108 | response to host immune response (GO:0052572) | 2.50016416 |
| 109 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.50016416 |
| 110 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.49797974 |
| 111 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.49590635 |
| 112 | amino sugar catabolic process (GO:0046348) | 2.48955381 |
| 113 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.48895496 |
| 114 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.47335064 |
| 115 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.47045046 |
| 116 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.46817658 |
| 117 | leukocyte mediated cytotoxicity (GO:0001909) | 2.45854074 |
| 118 | dendritic cell differentiation (GO:0097028) | 2.45674507 |
| 119 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.45338010 |
| 120 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.44582455 |
| 121 | detection of biotic stimulus (GO:0009595) | 2.44467304 |
| 122 | GDP-mannose metabolic process (GO:0019673) | 2.43886454 |
| 123 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.43537221 |
| 124 | natural killer cell differentiation (GO:0001779) | 2.42961874 |
| 125 | regulation of leukocyte degranulation (GO:0043300) | 2.42623575 |
| 126 | response to interferon-alpha (GO:0035455) | 2.42529430 |
| 127 | positive regulation of lamellipodium assembly (GO:0010592) | 2.42265498 |
| 128 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.41952661 |
| 129 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.41795690 |
| 130 | regulation of chemokine biosynthetic process (GO:0045073) | 2.41536106 |
| 131 | negative T cell selection (GO:0043383) | 2.40931901 |
| 132 | regulation of mast cell activation (GO:0033003) | 2.38533797 |
| 133 | thymic T cell selection (GO:0045061) | 2.38306776 |
| 134 | response to host (GO:0075136) | 2.37900004 |
| 135 | response to host defenses (GO:0052200) | 2.37900004 |
| 136 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.37900004 |
| 137 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.37377908 |
| 138 | interferon-gamma secretion (GO:0072643) | 2.36981929 |
| 139 | negative regulation of interleukin-6 production (GO:0032715) | 2.34615280 |
| 140 | T cell selection (GO:0045058) | 2.34512661 |
| 141 | positive regulation of mast cell activation (GO:0033005) | 2.33142089 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.63210762 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.39806930 |
| 3 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.99932100 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.56723051 |
| 5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.24795142 |
| 6 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.20852462 |
| 7 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.20641582 |
| 8 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.74184818 |
| 9 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.70058291 |
| 10 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.56350635 |
| 11 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.53099182 |
| 12 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.51905750 |
| 13 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.41822851 |
| 14 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.40146897 |
| 15 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.36936126 |
| 16 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.35900535 |
| 17 | MYC_22102868_ChIP-Seq_BL_Human | 2.34865815 |
| 18 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.31778980 |
| 19 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.29700534 |
| 20 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.24668682 |
| 21 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.23373523 |
| 22 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.21377182 |
| 23 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.17974069 |
| 24 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.09609497 |
| 25 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.05425315 |
| 26 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.03047618 |
| 27 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.01783739 |
| 28 | MYB_26560356_Chip-Seq_TH2_Human | 1.99707316 |
| 29 | * MAF_26560356_Chip-Seq_TH1_Human | 1.97073666 |
| 30 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.91720956 |
| 31 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.90270273 |
| 32 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.86926825 |
| 33 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.84722206 |
| 34 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.80624903 |
| 35 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.80319526 |
| 36 | MYB_26560356_Chip-Seq_TH1_Human | 1.74099248 |
| 37 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.72242999 |
| 38 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.71219681 |
| 39 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.70398776 |
| 40 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.67797066 |
| 41 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.65580699 |
| 42 | UTX_26944678_Chip-Seq_JUKART_Human | 1.60361618 |
| 43 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58660392 |
| 44 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.55077836 |
| 45 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.53266908 |
| 46 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.52897060 |
| 47 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.52150952 |
| 48 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.48025658 |
| 49 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.44349375 |
| 50 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.43357520 |
| 51 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.42413448 |
| 52 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.41611313 |
| 53 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.41270598 |
| 54 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.39892642 |
| 55 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39088463 |
| 56 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.38696424 |
| 57 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.38372779 |
| 58 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.38266604 |
| 59 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.38058024 |
| 60 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.35727194 |
| 61 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.35090333 |
| 62 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.34548497 |
| 63 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.34363158 |
| 64 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.32147114 |
| 65 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.31481097 |
| 66 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.30970015 |
| 67 | * MAF_26560356_Chip-Seq_TH2_Human | 1.30642684 |
| 68 | GATA1_22025678_ChIP-Seq_K562_Human | 1.30355935 |
| 69 | * P68_20966046_ChIP-Seq_HELA_Human | 1.29153716 |
| 70 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.29026958 |
| 71 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.27313904 |
| 72 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.27277498 |
| 73 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.26691389 |
| 74 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.26619820 |
| 75 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.26222341 |
| 76 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.24320083 |
| 77 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.22766350 |
| 78 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.22750890 |
| 79 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.21999984 |
| 80 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.21955307 |
| 81 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.21824848 |
| 82 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.19565420 |
| 83 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.17550670 |
| 84 | * P300_27268052_Chip-Seq_Bcells_Human | 1.16945373 |
| 85 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.16771161 |
| 86 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.16498271 |
| 87 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.16430015 |
| 88 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.15468535 |
| 89 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.15086732 |
| 90 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.15084379 |
| 91 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.14491397 |
| 92 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.14113583 |
| 93 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.13409721 |
| 94 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.12482890 |
| 95 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.10942102 |
| 96 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.10220773 |
| 97 | * CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.09233309 |
| 98 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.08704228 |
| 99 | SA1_27219007_Chip-Seq_Bcells_Human | 1.08041019 |
| 100 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.07838025 |
| 101 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.07796107 |
| 102 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.07226595 |
| 103 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.07170840 |
| 104 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.05792170 |
| 105 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.05764874 |
| 106 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.04544306 |
| 107 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.04111887 |
| 108 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.02821950 |
| 109 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.02545810 |
| 110 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.02328945 |
| 111 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.02233164 |
| 112 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.01471694 |
| 113 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.01294218 |
| 114 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01208492 |
| 115 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.97030948 |
| 116 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.96503521 |
| 117 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.95269437 |
| 118 | * GATA3_26560356_Chip-Seq_TH2_Human | 0.94910328 |
| 119 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.94142660 |
| 120 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.93600924 |
| 121 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.92170730 |
| 122 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.92001522 |
| 123 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.91734455 |
| 124 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.89421647 |
| 125 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.89261130 |
| 126 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.88646881 |
| 127 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.87874998 |
| 128 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.86229407 |
| 129 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.84499306 |
| 130 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.84055199 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.92190713 |
| 2 | MP0000685_abnormal_immune_system | 3.42494336 |
| 3 | MP0009785_altered_susceptibility_to | 3.35074424 |
| 4 | MP0003436_decreased_susceptibility_to | 3.27455541 |
| 5 | MP0001790_abnormal_immune_system | 3.16686288 |
| 6 | MP0005387_immune_system_phenotype | 3.16686288 |
| 7 | MP0001800_abnormal_humoral_immune | 3.15300560 |
| 8 | MP0002148_abnormal_hypersensitivity_rea | 3.06667430 |
| 9 | MP0005000_abnormal_immune_tolerance | 3.05954499 |
| 10 | MP0005671_abnormal_response_to | 3.00605238 |
| 11 | MP0002452_abnormal_antigen_presenting | 2.87830596 |
| 12 | MP0005025_abnormal_response_to | 2.73388310 |
| 13 | MP0002723_abnormal_immune_serum | 2.66014322 |
| 14 | MP0002419_abnormal_innate_immunity | 2.61173672 |
| 15 | MP0002139_abnormal_hepatobiliary_system | 2.53237666 |
| 16 | MP0002420_abnormal_adaptive_immunity | 2.50442211 |
| 17 | MP0001819_abnormal_immune_cell | 2.48603245 |
| 18 | MP0003303_peritoneal_inflammation | 2.31366114 |
| 19 | MP0003724_increased_susceptibility_to | 2.22219215 |
| 20 | MP0006082_CNS_inflammation | 2.18413967 |
| 21 | MP0002398_abnormal_bone_marrow | 2.12447940 |
| 22 | MP0003806_abnormal_nucleotide_metabolis | 2.12169198 |
| 23 | MP0005464_abnormal_platelet_physiology | 2.07887469 |
| 24 | MP0002405_respiratory_system_inflammati | 2.07035222 |
| 25 | MP0005360_urolithiasis | 2.06932524 |
| 26 | MP0001853_heart_inflammation | 2.06881096 |
| 27 | MP0009333_abnormal_splenocyte_physiolog | 2.05020391 |
| 28 | MP0000716_abnormal_immune_system | 2.03549235 |
| 29 | MP0002166_altered_tumor_susceptibility | 1.96612909 |
| 30 | MP0003763_abnormal_thymus_physiology | 1.94546733 |
| 31 | MP0001845_abnormal_inflammatory_respons | 1.87448450 |
| 32 | MP0005451_abnormal_body_composition | 1.87210898 |
| 33 | MP0000689_abnormal_spleen_morphology | 1.85396740 |
| 34 | MP0010155_abnormal_intestine_physiology | 1.81931877 |
| 35 | MP0002429_abnormal_blood_cell | 1.72354217 |
| 36 | MP0001533_abnormal_skeleton_physiology | 1.72095431 |
| 37 | MP0004510_myositis | 1.71880367 |
| 38 | MP0002006_tumorigenesis | 1.71782389 |
| 39 | MP0002722_abnormal_immune_system | 1.71447939 |
| 40 | MP0002396_abnormal_hematopoietic_system | 1.67808332 |
| 41 | MP0004947_skin_inflammation | 1.60772620 |
| 42 | MP0008469_abnormal_protein_level | 1.59760913 |
| 43 | MP0002933_joint_inflammation | 1.55657520 |
| 44 | MP0005058_abnormal_lysosome_morphology | 1.53920515 |
| 45 | MP0003191_abnormal_cellular_cholesterol | 1.52541712 |
| 46 | MP0009840_abnormal_foam_cell | 1.40362863 |
| 47 | MP0003300_gastrointestinal_ulcer | 1.40070470 |
| 48 | MP0005365_abnormal_bile_salt | 1.39165621 |
| 49 | MP0009764_decreased_sensitivity_to | 1.38881685 |
| 50 | MP0000858_altered_metastatic_potential | 1.38318158 |
| 51 | MP0001873_stomach_inflammation | 1.36941086 |
| 52 | MP0000343_altered_response_to | 1.35893579 |
| 53 | MP0004808_abnormal_hematopoietic_stem | 1.31369943 |
| 54 | MP0001545_abnormal_hematopoietic_system | 1.30424063 |
| 55 | MP0005397_hematopoietic_system_phenotyp | 1.30424063 |
| 56 | MP0003866_abnormal_defecation | 1.23481303 |
| 57 | MP0005310_abnormal_salivary_gland | 1.23160848 |
| 58 | MP0003186_abnormal_redox_activity | 1.23111987 |
| 59 | MP0005085_abnormal_gallbladder_physiolo | 1.20685296 |
| 60 | MP0008260_abnormal_autophagy | 1.19272246 |
| 61 | MP0000490_abnormal_crypts_of | 1.09165161 |
| 62 | MP0000703_abnormal_thymus_morphology | 1.08205121 |
| 63 | MP0003448_altered_tumor_morphology | 1.04733787 |
| 64 | MP0002998_abnormal_bone_remodeling | 1.03158515 |
| 65 | MP0003172_abnormal_lysosome_physiology | 1.03150930 |
| 66 | MP0000604_amyloidosis | 1.02346304 |
| 67 | MP0000465_gastrointestinal_hemorrhage | 1.01620667 |
| 68 | MP0006054_spinal_hemorrhage | 1.01532164 |
| 69 | MP0002138_abnormal_hepatobiliary_system | 0.98214304 |
| 70 | MP0008438_abnormal_cutaneous_collagen | 0.98167761 |
| 71 | MP0009278_abnormal_bone_marrow | 0.95662840 |
| 72 | MP0002019_abnormal_tumor_incidence | 0.92596769 |
| 73 | MP0003279_aneurysm | 0.92371029 |
| 74 | MP0009763_increased_sensitivity_to | 0.90549675 |
| 75 | MP0005174_abnormal_tail_pigmentation | 0.89143642 |
| 76 | MP0001666_abnormal_nutrient_absorption | 0.86257129 |
| 77 | MP0005381_digestive/alimentary_phenotyp | 0.85177300 |
| 78 | MP0005166_decreased_susceptibility_to | 0.83401156 |
| 79 | MP0001764_abnormal_homeostasis | 0.83310096 |
| 80 | MP0002136_abnormal_kidney_physiology | 0.83130843 |
| 81 | MP0004019_abnormal_vitamin_homeostasis | 0.82331410 |
| 82 | MP0003656_abnormal_erythrocyte_physiolo | 0.81717645 |
| 83 | MP0000249_abnormal_blood_vessel | 0.81254747 |
| 84 | MP0008875_abnormal_xenobiotic_pharmacok | 0.80892254 |
| 85 | MP0005390_skeleton_phenotype | 0.80280446 |
| 86 | MP0003566_abnormal_cell_adhesion | 0.79417015 |
| 87 | MP0003183_abnormal_peptide_metabolism | 0.79071014 |
| 88 | MP0004883_abnormal_blood_vessel | 0.78511327 |
| 89 | MP0003075_altered_response_to | 0.77279941 |
| 90 | MP0002132_abnormal_respiratory_system | 0.75821607 |
| 91 | MP0005165_increased_susceptibility_to | 0.74725465 |
| 92 | MP0000609_abnormal_liver_physiology | 0.73275742 |
| 93 | MP0010307_abnormal_tumor_latency | 0.72812529 |
| 94 | MP0009643_abnormal_urine_homeostasis | 0.72525801 |
| 95 | MP0005023_abnormal_wound_healing | 0.72253458 |
| 96 | MP0010329_abnormal_lipoprotein_level | 0.71735378 |
| 97 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.71044567 |
| 98 | MP0003828_pulmonary_edema | 0.70506532 |
| 99 | MP0000598_abnormal_liver_morphology | 0.70119094 |
| 100 | MP0008004_abnormal_stomach_pH | 0.69107093 |
| 101 | MP0003252_abnormal_bile_duct | 0.68566377 |
| 102 | MP0005319_abnormal_enzyme/_coenzyme | 0.67204107 |
| 103 | MP0001663_abnormal_digestive_system | 0.65486482 |
| 104 | MP0002118_abnormal_lipid_homeostasis | 0.64998256 |
| 105 | MP0004782_abnormal_surfactant_physiolog | 0.64305120 |
| 106 | MP0001348_abnormal_lacrimal_gland | 0.63620501 |
| 107 | MP0003795_abnormal_bone_structure | 0.63566588 |
| 108 | MP0008874_decreased_physiological_sensi | 0.63302025 |
| 109 | MP0001986_abnormal_taste_sensitivity | 0.63135445 |
| 110 | MP0001851_eye_inflammation | 0.62526345 |
| 111 | MP0002277_abnormal_respiratory_mucosa | 0.61404756 |
| 112 | MP0010352_gastrointestinal_tract_polyps | 0.61235473 |
| 113 | MP0009642_abnormal_blood_homeostasis | 0.60107940 |
| 114 | MP0002254_reproductive_system_inflammat | 0.58475039 |
| 115 | MP0005075_abnormal_melanosome_morpholog | 0.57934091 |
| 116 | MP0001958_emphysema | 0.57534373 |
| 117 | MP0005164_abnormal_response_to | 0.55911586 |
| 118 | MP0008873_increased_physiological_sensi | 0.54675069 |
| 119 | MP0000015_abnormal_ear_pigmentation | 0.53840309 |
| 120 | MP0003045_fibrosis | 0.53570965 |
| 121 | MP0003091_abnormal_cell_migration | 0.53304440 |
| 122 | MP0002693_abnormal_pancreas_physiology | 0.52237201 |
| 123 | MP0002135_abnormal_kidney_morphology | 0.51929224 |
| 124 | MP0001542_abnormal_bone_strength | 0.51197376 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 5.22831250 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 4.85276346 |
| 3 | Eczematoid dermatitis (HP:0000976) | 4.79999525 |
| 4 | Agammaglobulinemia (HP:0004432) | 4.65105396 |
| 5 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.53774152 |
| 6 | Cellulitis (HP:0100658) | 4.26469370 |
| 7 | Recurrent bronchitis (HP:0002837) | 4.08852910 |
| 8 | Autoimmune thrombocytopenia (HP:0001973) | 3.92897127 |
| 9 | Gastrointestinal stroma tumor (HP:0100723) | 3.91864966 |
| 10 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.90975994 |
| 11 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.90975994 |
| 12 | Abnormality of glycolipid metabolism (HP:0010969) | 3.90975994 |
| 13 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.85973010 |
| 14 | IgM deficiency (HP:0002850) | 3.78215335 |
| 15 | Myositis (HP:0100614) | 3.78184578 |
| 16 | Recurrent fungal infections (HP:0002841) | 3.65964269 |
| 17 | Recurrent viral infections (HP:0004429) | 3.61228622 |
| 18 | Recurrent skin infections (HP:0001581) | 3.60250940 |
| 19 | Meningitis (HP:0001287) | 3.55901397 |
| 20 | Vasculitis (HP:0002633) | 3.54556527 |
| 21 | Thrombocytosis (HP:0001894) | 3.54322072 |
| 22 | Mediastinal lymphadenopathy (HP:0100721) | 3.39872127 |
| 23 | Vacuolated lymphocytes (HP:0001922) | 3.28575225 |
| 24 | Abnormality of macrophages (HP:0004311) | 3.25984693 |
| 25 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.24702585 |
| 26 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.19667479 |
| 27 | Recurrent cutaneous fungal infections (HP:0011370) | 3.19667479 |
| 28 | Interstitial pulmonary disease (HP:0006530) | 3.18775942 |
| 29 | Lymphopenia (HP:0001888) | 3.07814998 |
| 30 | Petechiae (HP:0000967) | 3.07504602 |
| 31 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.07074442 |
| 32 | Recurrent lower respiratory tract infections (HP:0002783) | 3.06550439 |
| 33 | Chronic otitis media (HP:0000389) | 3.06327886 |
| 34 | Abnormality of T cell physiology (HP:0011840) | 3.03294442 |
| 35 | Inflammation of the large intestine (HP:0002037) | 3.01986821 |
| 36 | Recurrent pneumonia (HP:0006532) | 3.01519151 |
| 37 | Osteomyelitis (HP:0002754) | 2.94548081 |
| 38 | Gastrointestinal inflammation (HP:0004386) | 2.93768860 |
| 39 | Chronic obstructive pulmonary disease (HP:0006510) | 2.92210114 |
| 40 | Obstructive lung disease (HP:0006536) | 2.92210114 |
| 41 | Colitis (HP:0002583) | 2.91118148 |
| 42 | Abnormality of T cells (HP:0002843) | 2.84560036 |
| 43 | Papilloma (HP:0012740) | 2.84428744 |
| 44 | Verrucae (HP:0200043) | 2.84428744 |
| 45 | Orchitis (HP:0100796) | 2.83820643 |
| 46 | Panhypogammaglobulinemia (HP:0003139) | 2.79038264 |
| 47 | Recurrent sinusitis (HP:0011108) | 2.76593256 |
| 48 | IgA deficiency (HP:0002720) | 2.65868172 |
| 49 | Systemic lupus erythematosus (HP:0002725) | 2.62792558 |
| 50 | Emphysema (HP:0002097) | 2.62774054 |
| 51 | Pustule (HP:0200039) | 2.62206294 |
| 52 | Malnutrition (HP:0004395) | 2.61522149 |
| 53 | Abnormality of T cell number (HP:0011839) | 2.59906274 |
| 54 | IgG deficiency (HP:0004315) | 2.56238741 |
| 55 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.53338203 |
| 56 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.53338203 |
| 57 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.53338203 |
| 58 | Vertebral compression fractures (HP:0002953) | 2.52633218 |
| 59 | Gingival bleeding (HP:0000225) | 2.47384849 |
| 60 | Optic neuritis (HP:0100653) | 2.44572411 |
| 61 | Retrobulbar optic neuritis (HP:0100654) | 2.44572411 |
| 62 | Purpura (HP:0000979) | 2.44428159 |
| 63 | Chronic sinusitis (HP:0011109) | 2.43963961 |
| 64 | Gingivitis (HP:0000230) | 2.43958160 |
| 65 | Sepsis (HP:0100806) | 2.41976292 |
| 66 | Increased serum ferritin (HP:0003281) | 2.41386447 |
| 67 | Spontaneous hematomas (HP:0007420) | 2.41048523 |
| 68 | Pulmonary infiltrates (HP:0002113) | 2.40597582 |
| 69 | Urticaria (HP:0001025) | 2.39429891 |
| 70 | T lymphocytopenia (HP:0005403) | 2.36887027 |
| 71 | Gastrointestinal infarctions (HP:0005244) | 2.36667905 |
| 72 | Hypergammaglobulinemia (HP:0010702) | 2.35849811 |
| 73 | Abnormality of B cell number (HP:0010975) | 2.35201350 |
| 74 | B lymphocytopenia (HP:0010976) | 2.35201350 |
| 75 | Thyroiditis (HP:0100646) | 2.31980743 |
| 76 | Periodontitis (HP:0000704) | 2.29109306 |
| 77 | Skin rash (HP:0000988) | 2.26346202 |
| 78 | Restrictive lung disease (HP:0002091) | 2.26067641 |
| 79 | Nasal polyposis (HP:0100582) | 2.25673545 |
| 80 | Basal ganglia calcification (HP:0002135) | 2.21628264 |
| 81 | Epistaxis (HP:0000421) | 2.21379061 |
| 82 | Arterial thrombosis (HP:0004420) | 2.21183833 |
| 83 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.20019278 |
| 84 | Poor head control (HP:0002421) | 2.20011275 |
| 85 | Increased IgM level (HP:0003496) | 2.17548677 |
| 86 | Hypertensive crisis (HP:0100735) | 2.14779088 |
| 87 | Skin ulcer (HP:0200042) | 2.14178276 |
| 88 | Chronic diarrhea (HP:0002028) | 2.12829920 |
| 89 | Leukocytosis (HP:0001974) | 2.12464243 |
| 90 | Hepatosplenomegaly (HP:0001433) | 2.11498975 |
| 91 | Bronchitis (HP:0012387) | 2.10689735 |
| 92 | Loss of speech (HP:0002371) | 2.10016727 |
| 93 | Neutropenia (HP:0001875) | 2.09965119 |
| 94 | Amyloidosis (HP:0011034) | 2.09894119 |
| 95 | Granulocytopenia (HP:0001913) | 2.09805555 |
| 96 | Dysostosis multiplex (HP:0000943) | 2.09689591 |
| 97 | Axonal loss (HP:0003447) | 2.09080646 |
| 98 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.08754758 |
| 99 | Abnormality of iron homeostasis (HP:0011031) | 2.08163825 |
| 100 | Abnormality of the nasal mucosa (HP:0000433) | 2.08155209 |
| 101 | Encephalitis (HP:0002383) | 2.05963598 |
| 102 | Arthralgia (HP:0002829) | 2.05936069 |
| 103 | Combined immunodeficiency (HP:0005387) | 2.05817980 |
| 104 | Stomatitis (HP:0010280) | 2.05520907 |
| 105 | Increased cerebral lipofuscin (HP:0011813) | 2.03359724 |
| 106 | Prolonged bleeding time (HP:0003010) | 1.98167399 |
| 107 | Hemoptysis (HP:0002105) | 1.97889018 |
| 108 | Mitral stenosis (HP:0001718) | 1.97852899 |
| 109 | Hemorrhage of the eye (HP:0011885) | 1.96429474 |
| 110 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.96123854 |
| 111 | Chest pain (HP:0100749) | 1.95489921 |
| 112 | Myocardial infarction (HP:0001658) | 1.94296259 |
| 113 | Mucopolysacchariduria (HP:0008155) | 1.93970824 |
| 114 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.93970824 |
| 115 | Increased IgE level (HP:0003212) | 1.93666297 |
| 116 | Glomerulonephritis (HP:0000099) | 1.92734697 |
| 117 | Abnormality of the pleura (HP:0002103) | 1.92489559 |
| 118 | Progressive neurologic deterioration (HP:0002344) | 1.92058549 |
| 119 | Severe combined immunodeficiency (HP:0004430) | 1.91616259 |
| 120 | Lymphoma (HP:0002665) | 1.90237353 |
| 121 | Prolonged neonatal jaundice (HP:0006579) | 1.90112301 |
| 122 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.89567398 |
| 123 | Eosinophilia (HP:0001880) | 1.89068809 |
| 124 | Abnormality of complement system (HP:0005339) | 1.88191557 |
| 125 | Premature loss of primary teeth (HP:0006323) | 1.86967783 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.69866569 |
| 2 | ERN1 | 3.55554225 |
| 3 | BLK | 3.34386837 |
| 4 | TBK1 | 2.82586086 |
| 5 | MAP3K14 | 2.57938472 |
| 6 | KIT | 2.51494603 |
| 7 | BTK | 2.47604008 |
| 8 | NME2 | 2.36346724 |
| 9 | TYK2 | 2.34597453 |
| 10 | PIM2 | 2.32137742 |
| 11 | JAK3 | 2.17300913 |
| 12 | CSF1R | 2.12842044 |
| 13 | ZAP70 | 2.12390804 |
| 14 | IKBKE | 2.11931856 |
| 15 | SYK | 2.08670103 |
| 16 | IRAK4 | 1.97602443 |
| 17 | IKBKB | 1.89511095 |
| 18 | TLK1 | 1.86203220 |
| 19 | TEC | 1.85573862 |
| 20 | LRRK2 | 1.63349444 |
| 21 | IRAK3 | 1.62122251 |
| 22 | RIPK4 | 1.61923084 |
| 23 | FLT3 | 1.60959087 |
| 24 | TXK | 1.56571028 |
| 25 | MAP2K3 | 1.55334061 |
| 26 | TRIB3 | 1.55161270 |
| 27 | PRPF4B | 1.47410579 |
| 28 | MAP3K10 | 1.45141395 |
| 29 | JAK1 | 1.42673341 |
| 30 | GRK6 | 1.41289458 |
| 31 | LYN | 1.41104131 |
| 32 | STK10 | 1.37217368 |
| 33 | EPHA2 | 1.33942701 |
| 34 | NEK9 | 1.31395931 |
| 35 | RPS6KA4 | 1.29786274 |
| 36 | TESK1 | 1.28645142 |
| 37 | TESK2 | 1.23822325 |
| 38 | TAOK2 | 1.23424619 |
| 39 | TAOK1 | 1.22185714 |
| 40 | CSK | 1.18887233 |
| 41 | CHUK | 1.18582926 |
| 42 | LCK | 1.17101368 |
| 43 | ITK | 1.16262208 |
| 44 | PIK3CG | 1.12922034 |
| 45 | KDR | 1.11367891 |
| 46 | HCK | 1.11332268 |
| 47 | PIM1 | 1.08717673 |
| 48 | TGFBR2 | 1.06012371 |
| 49 | MAP3K1 | 1.06005189 |
| 50 | PKN2 | 1.05301338 |
| 51 | FGFR4 | 1.02304169 |
| 52 | ACVR1B | 0.97968416 |
| 53 | MAP3K13 | 0.96142124 |
| 54 | MATK | 0.94145848 |
| 55 | PRKD2 | 0.93932752 |
| 56 | ARAF | 0.90583626 |
| 57 | MST1R | 0.88292667 |
| 58 | EEF2K | 0.86614152 |
| 59 | EIF2AK1 | 0.84192674 |
| 60 | CDC42BPA | 0.83326533 |
| 61 | SCYL2 | 0.82630575 |
| 62 | TAOK3 | 0.81486496 |
| 63 | MAP2K2 | 0.81224024 |
| 64 | MST4 | 0.79433411 |
| 65 | MAP3K11 | 0.77529808 |
| 66 | SIK3 | 0.77217500 |
| 67 | EIF2AK3 | 0.75690221 |
| 68 | CLK1 | 0.72817480 |
| 69 | NLK | 0.72448022 |
| 70 | BMPR2 | 0.72372636 |
| 71 | MAP2K6 | 0.71043201 |
| 72 | GRK7 | 0.70945109 |
| 73 | BCKDK | 0.69959847 |
| 74 | PDPK1 | 0.69619067 |
| 75 | BUB1 | 0.69131570 |
| 76 | CDK19 | 0.68326810 |
| 77 | PDK1 | 0.66295018 |
| 78 | FGFR3 | 0.65988502 |
| 79 | FGR | 0.65319927 |
| 80 | HIPK2 | 0.65141836 |
| 81 | MAPK12 | 0.64399908 |
| 82 | SMG1 | 0.64395870 |
| 83 | MAP3K12 | 0.63406208 |
| 84 | ILK | 0.63087998 |
| 85 | MAPK7 | 0.61779884 |
| 86 | TRPM7 | 0.60479395 |
| 87 | MAP3K3 | 0.60164124 |
| 88 | STK4 | 0.60034433 |
| 89 | TGFBR1 | 0.59433188 |
| 90 | PRKCQ | 0.57394639 |
| 91 | EPHB1 | 0.57243351 |
| 92 | MYLK | 0.56828699 |
| 93 | JAK2 | 0.55698338 |
| 94 | MAPKAPK2 | 0.55263194 |
| 95 | MARK3 | 0.54535389 |
| 96 | PRKCD | 0.54292080 |
| 97 | LMTK2 | 0.51916798 |
| 98 | SIK1 | 0.50405046 |
| 99 | ABL2 | 0.50364070 |
| 100 | RPS6KA6 | 0.49835045 |
| 101 | TNK2 | 0.49686993 |
| 102 | ADRBK2 | 0.49403803 |
| 103 | VRK2 | 0.47829759 |
| 104 | MAPK11 | 0.47123887 |
| 105 | FES | 0.45573440 |
| 106 | PRKCH | 0.44525601 |
| 107 | EPHA3 | 0.44349131 |
| 108 | EPHB2 | 0.44057968 |
| 109 | DDR2 | 0.42474381 |
| 110 | SIK2 | 0.42473744 |
| 111 | PBK | 0.42073689 |
| 112 | ABL1 | 0.41169426 |
| 113 | ADRBK1 | 0.41075593 |
| 114 | MAPKAPK3 | 0.38896115 |
| 115 | LIMK1 | 0.38557318 |
| 116 | FYN | 0.38506605 |
| 117 | MAPK4 | 0.35834406 |
| 118 | MAP3K8 | 0.35286833 |
| 119 | PAK4 | 0.34801309 |
| 120 | PTK6 | 0.34323168 |
| 121 | IRAK1 | 0.34017651 |
| 122 | RPS6KC1 | 0.31946106 |
| 123 | RPS6KL1 | 0.31946106 |
| 124 | MOS | 0.30621333 |
| 125 | CDK4 | 0.29903440 |
| 126 | PRKG2 | 0.29708687 |
| 127 | DAPK3 | 0.28483569 |
| 128 | DYRK1B | 0.27812839 |
| 129 | RAF1 | 0.26950721 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.61145086 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.90524696 |
| 3 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.78082255 |
| 4 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.63438193 |
| 5 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.52303005 |
| 6 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.51984674 |
| 7 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.25743301 |
| 8 | Allograft rejection_Homo sapiens_hsa05330 | 2.19406366 |
| 9 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.17344310 |
| 10 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.08701705 |
| 11 | Measles_Homo sapiens_hsa05162 | 2.08658507 |
| 12 | Legionellosis_Homo sapiens_hsa05134 | 2.07649940 |
| 13 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.06675538 |
| 14 | Ribosome_Homo sapiens_hsa03010 | 2.04008910 |
| 15 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.03678642 |
| 16 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.98067642 |
| 17 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.93384068 |
| 18 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.76327198 |
| 19 | Tuberculosis_Homo sapiens_hsa05152 | 1.72445875 |
| 20 | Pertussis_Homo sapiens_hsa05133 | 1.70578878 |
| 21 | Malaria_Homo sapiens_hsa05144 | 1.64735597 |
| 22 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.61719642 |
| 23 | Asthma_Homo sapiens_hsa05310 | 1.59256833 |
| 24 | Other glycan degradation_Homo sapiens_hsa00511 | 1.57310766 |
| 25 | Shigellosis_Homo sapiens_hsa05131 | 1.55554037 |
| 26 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.52216005 |
| 27 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.49261941 |
| 28 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.47658907 |
| 29 | Proteasome_Homo sapiens_hsa03050 | 1.45912844 |
| 30 | Apoptosis_Homo sapiens_hsa04210 | 1.41957780 |
| 31 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.40818557 |
| 32 | Influenza A_Homo sapiens_hsa05164 | 1.40334621 |
| 33 | Lysosome_Homo sapiens_hsa04142 | 1.37480468 |
| 34 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.35953219 |
| 35 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.34931757 |
| 36 | Salmonella infection_Homo sapiens_hsa05132 | 1.30643739 |
| 37 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.26453352 |
| 38 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.25381236 |
| 39 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.23798277 |
| 40 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.23754508 |
| 41 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.23083010 |
| 42 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.22121001 |
| 43 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.20128479 |
| 44 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.14921164 |
| 45 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.13489147 |
| 46 | Viral myocarditis_Homo sapiens_hsa05416 | 1.13216467 |
| 47 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.05694359 |
| 48 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.04765275 |
| 49 | Hepatitis B_Homo sapiens_hsa05161 | 1.03364529 |
| 50 | Protein export_Homo sapiens_hsa03060 | 1.02518652 |
| 51 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.99978831 |
| 52 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.99857811 |
| 53 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.99247686 |
| 54 | Phagosome_Homo sapiens_hsa04145 | 0.98302982 |
| 55 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.96979902 |
| 56 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.96549207 |
| 57 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.96013658 |
| 58 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.94508736 |
| 59 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.91135253 |
| 60 | * DNA replication_Homo sapiens_hsa03030 | 0.89803322 |
| 61 | * Base excision repair_Homo sapiens_hsa03410 | 0.89274668 |
| 62 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.88896497 |
| 63 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.86864473 |
| 64 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.86690381 |
| 65 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.82105915 |
| 66 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.78736436 |
| 67 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.78592219 |
| 68 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.77772617 |
| 69 | Platelet activation_Homo sapiens_hsa04611 | 0.77359616 |
| 70 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.73885592 |
| 71 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.72338336 |
| 72 | Hepatitis C_Homo sapiens_hsa05160 | 0.70886999 |
| 73 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.70431388 |
| 74 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.69848869 |
| 75 | Mineral absorption_Homo sapiens_hsa04978 | 0.68023763 |
| 76 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.65936571 |
| 77 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.64437878 |
| 78 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.64307967 |
| 79 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.63781634 |
| 80 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.63612461 |
| 81 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.61499041 |
| 82 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.59425455 |
| 83 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.57800642 |
| 84 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.57281544 |
| 85 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.57185398 |
| 86 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.57000733 |
| 87 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.56904763 |
| 88 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.56138380 |
| 89 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.54090083 |
| 90 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.53475961 |
| 91 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.52316927 |
| 92 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.50153292 |
| 93 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.50123186 |
| 94 | Galactose metabolism_Homo sapiens_hsa00052 | 0.48738615 |
| 95 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.48497944 |
| 96 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.47194686 |
| 97 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.46348173 |
| 98 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.45837426 |
| 99 | Sulfur relay system_Homo sapiens_hsa04122 | 0.44212401 |
| 100 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.43980575 |
| 101 | * Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.42123061 |
| 102 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.41621960 |
| 103 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.41436692 |
| 104 | Retinol metabolism_Homo sapiens_hsa00830 | 0.41429927 |
| 105 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.41298112 |
| 106 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.40500374 |
| 107 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.39442756 |
| 108 | * HTLV-I infection_Homo sapiens_hsa05166 | 0.38961714 |
| 109 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.38642175 |
| 110 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.38365037 |
| 111 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.36172028 |
| 112 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.36059424 |
| 113 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.35855431 |
| 114 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.35445961 |
| 115 | Amoebiasis_Homo sapiens_hsa05146 | 0.33523626 |
| 116 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.33196725 |
| 117 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.32278789 |
| 118 | Endocytosis_Homo sapiens_hsa04144 | 0.31392916 |
| 119 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.31340310 |
| 120 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.30056921 |
| 121 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.25352133 |
| 122 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.25052422 |
| 123 | Insulin resistance_Homo sapiens_hsa04931 | 0.24144750 |
| 124 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.23888510 |
| 125 | Peroxisome_Homo sapiens_hsa04146 | 0.22970048 |
| 126 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.22304773 |
| 127 | Histidine metabolism_Homo sapiens_hsa00340 | 0.20460693 |
| 128 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.19685034 |

